CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Valiant Laboratories Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Valiant Laboratories Ltd
Phone: +91 2249712001p:+91 2249712001 MUMBAI, 400080  India Ticker: VALIANTLABVALIANTLAB
Business Summary
Valiant Laboratories Limited is an India-based active pharmaceutical ingredient (API)manufacturing company. The Company is engaged in manufacturing and dealing in specialty chemicals and pharma intermediates in India and abroad. The Company is focused on manufacturing paracetamol API/bulk drug, which has various applications like uses in treatment of conditions, such as headache, muscle ache, arthritis, back ache, toothache, cold and fever. It operates in a single location manufacturing facility at Tarapur industrial estate. Its manufacturing facility is located at a distance of approximately 150 kilometers (km) from Nhava Sheva Port (JNPT). The Company’s subsidiary is VALIANT ADVANCED SCIENCES PRIVATE LIMITED.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20243/31/2024Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Financial Officer, Executive Director Paresh S.Shah 63 2/6/2022 8/16/2021
Compliance Officer, Company Secretary PrajaktaPatil 5/14/2024 5/14/2024
Managing Director, Executive Director Santosh S.Vora 29 2/6/2022 8/16/2021
12 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 43,450,000 (As of 9/30/2024)
Stock Exchange: NSE
Email Address: marketing@valiantlabs.in


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, November 22, 2024